Ascentage Pharma Group International (ASPHF)
USD 2.69
(0.0%)
USD 2.69
(0.0%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 2.5 Billion CNY | -11.66% |
| 2022 | 2.83 Billion CNY | -3.73% |
| 2021 | 2.94 Billion CNY | 69.84% |
| 2020 | 1.73 Billion CNY | 43.65% |
| 2019 | 1.2 Billion CNY | -1.98% |
| 2018 | 1.22 Billion CNY | 111.36% |
| 2017 | 581.66 Million CNY | -1.97% |
| 2016 | 593.34 Million CNY | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 Q2 | 2.91 Billion CNY | 0.0% |
| 2023 Q4 | 2.5 Billion CNY | 0.0% |
| 2023 FY | 2.5 Billion CNY | -11.66% |
| 2023 Q3 | 2.5 Billion CNY | -14.31% |
| 2023 Q1 | 2.91 Billion CNY | 3.1% |
| 2022 Q4 | 2.83 Billion CNY | 0.0% |
| 2022 Q2 | 3.03 Billion CNY | 0.0% |
| 2022 Q1 | 3.03 Billion CNY | 3.23% |
| 2022 FY | 2.83 Billion CNY | -3.73% |
| 2022 Q3 | 2.83 Billion CNY | -6.74% |
| 2021 Q4 | 2.94 Billion CNY | 0.0% |
| 2021 FY | 2.94 Billion CNY | 69.84% |
| 2021 Q3 | 2.94 Billion CNY | 22.09% |
| 2021 Q2 | 2.4 Billion CNY | 0.0% |
| 2021 Q1 | 2.4 Billion CNY | 39.12% |
| 2020 Q2 | 1.1 Billion CNY | 0.0% |
| 2020 FY | 1.73 Billion CNY | 43.65% |
| 2020 Q4 | 1.73 Billion CNY | 0.0% |
| 2020 Q3 | 1.73 Billion CNY | 56.58% |
| 2020 Q1 | 1.1 Billion CNY | -8.26% |
| 2019 Q3 | 1.2 Billion CNY | 12.41% |
| 2019 Q2 | 1.07 Billion CNY | 0.0% |
| 2019 Q1 | 1.07 Billion CNY | -12.8% |
| 2019 FY | 1.2 Billion CNY | -1.98% |
| 2019 Q4 | 1.2 Billion CNY | 0.0% |
| 2018 Q3 | 1.22 Billion CNY | 0.0% |
| 2018 FY | 1.22 Billion CNY | 111.36% |
| 2018 Q4 | 1.22 Billion CNY | 0.0% |
| 2018 Q1 | - CNY | 0.0% |
| 2017 FY | 581.66 Million CNY | -1.97% |
| 2016 FY | 593.34 Million CNY | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Eiger BioPharmaceuticals, Inc. | 38.84 Million USD | -6336.515% |
| Nanobac Pharmaceuticals, Incorporated | 7.21 Million USD | -34532.624% |
| SQZ Biotechnologies Company | 107.18 Million USD | -2232.739% |
| Evofem Biosciences, Inc. | 10.55 Million USD | -23591.425% |
| Santhera Pharmaceuticals Holding AG | 130.21 Million USD | -1820.266% |
| Mesoblast Limited | 667.9 Million USD | -274.366% |
| Propanc Biopharma, Inc. | 72.36 Thousand USD | -3455151.848% |
| Genus plc | 1.02 Billion USD | -143.016% |
| VioQuest Pharmaceuticals, Inc. | 1.35 Million USD | -183975.347% |
| CNBX Pharmaceuticals Inc. | 499.03 Thousand USD | -500941.602% |
| Marizyme, Inc. | 22.01 Million USD | -11257.64% |
| ContraFect Corporation | 20.67 Million USD | -11991.46% |
| Nymox Pharmaceutical Corporation | 627 Thousand USD | -398686.762% |
| PsyBio Therapeutics Corp. | 390.36 Thousand USD | -640425.302% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 382.17 Thousand USD | -654149.994% |
| Intellipharmaceutics International Inc. | 1.43 Million USD | -174504.548% |
| AXIM Biotechnologies, Inc. | 4.14 Million USD | -60208.242% |
| MultiCell Technologies, Inc. | 126.22 USD | -1980979934.86% |
| Accustem Sciences Inc. | 939.68 Thousand USD | -265987.291% |
| RVL Pharmaceuticals plc | 128.51 Million USD | -1845.68% |
| EV Biologics, Inc. | 431.71 Thousand USD | -579078.113% |
| Q BioMed Inc. | 3.51 Million USD | -71024.475% |
| Emmaus Life Sciences, Inc. | 35.17 Million USD | -7007.63% |
| Neon Bloom, Inc. | 770.64 Thousand USD | -324355.001% |
| Mosaic ImmunoEngineering Inc. | 261.27 Thousand USD | -956889.326% |
| Biomind Labs Inc. | 73.81 Thousand USD | -3387094.354% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| Pharming Group N.V. | 462.85 Million USD | -440.212% |
| Oncotelic Therapeutics, Inc. | 30.01 Million USD | -8230.491% |
| Skye Bioscience, Inc. | 11.94 Million USD | -20840.594% |
| Therapeutic Solutions International, Inc. | 3.31 Million USD | -75371.897% |
| THC Farmaceuticals, Inc. | 2.74 Million USD | -90944.72% |
| Arch Therapeutics, Inc. | 1.95 Million USD | -127589.054% |
| IMV Inc. | 31.33 Million USD | -7879.862% |
| Acro Biomedical Co., Ltd. | 687.48 Thousand USD | -363600.934% |
| Curative Biotechnology, Inc. | 2.6 Million USD | -95950.893% |
| GB Sciences, Inc. | 103.44 Thousand USD | -2417093.21% |
| Alpha Cognition Inc. | 2.45 Million USD | -101866.544% |
| HST Global, Inc. | 1526.00 USD | -163852652.294% |
| CSL Limited | 38.02 Billion USD | 93.424% |
| Halberd Corporation | 10.13 Thousand USD | -24680513.957% |
| Enzolytics Inc. | 361.7 Million USD | -591.277% |
| Resverlogix Corp. | 8.11 Million USD | -30711.99% |
| Affymax, Inc. | 7.44 Million USD | -33493.887% |
| SYBLEU INC | 330.46 Thousand USD | -756521.821% |
| Nuo Therapeutics, Inc. | 1.87 Million USD | -133049.775% |
| argenx SE | 4.54 Billion USD | 44.955% |
| MetaStat, Inc. | - USD | -Infinity% |
| Northwest Biotherapeutics, Inc. | 27.94 Million USD | -8847.871% |
| Enzon Pharmaceuticals, Inc. | 47.7 Million USD | -5141.694% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| RespireRx Pharmaceuticals Inc. | 22.78 Thousand USD | -10975682.45% |
| GeneThera, Inc. | - USD | -Infinity% |
| Inhibitor Therapeutics, Inc. | 8.94 Million USD | -27839.99% |
| AVAX Technologies, Inc. | 7.37 Million USD | -33793.721% |
| Zenith Capital Corp. | 7410.00 USD | -33743395.277% |
| Genscript Biotech Corporation | 3.38 Billion USD | 26.163% |
| Ember Therapeutics, Inc. | 184.00 USD | -1358909139.13% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | 321.8 Thousand USD | -776887.688% |
| WPD Pharmaceuticals Inc. | 261.36 Thousand USD | -956570.773% |
| American Oriental Bioengineering, Inc. | 446.3 Million USD | -460.238% |
| Provectus Biopharmaceuticals, Inc. | 1.44 Million USD | -172478.602% |
| Adynxx, Inc. | - USD | -Infinity% |
| Helix BioMedix, Inc. | 3.02 Million USD | -82555.27% |
| GlobeStar Therapeutics Corporation | - USD | -Infinity% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Capstone Therapeutics Corp. | 52.7 Million USD | -4644.489% |
| Cotinga Pharmaceuticals Inc. | 927.96 Thousand USD | -269350.225% |
| BioStem Technologies, Inc. | 14.56 Million USD | -17072.686% |
| ONE Bio Corp. | 70.08 Million USD | -3467.632% |
| Reve Technologies, Inc. | 57.09 Thousand USD | -4379332.165% |
| Burzynski Research Institute, Inc. | 2310.00 USD | -108242021.212% |
| Wesana Health Holdings Inc. | 987.96 Thousand USD | -252984.668% |
| Agentix Corp. | 261.39 Thousand USD | -956468.296% |
| LadRx Corporation | 2.3 Million USD | -108241.458% |
| Cell Source, Inc. | 195.17 Thousand USD | -1281029.369% |
| ProtoKinetix, Incorporated | 480.55 Thousand USD | -520211.43% |
| Regen BioPharma, Inc. | 353.61 Thousand USD | -706990.722% |
| Regen BioPharma, Inc. | 353.61 Thousand USD | -706990.722% |
| NovAccess Global Inc. | 62.24 Thousand USD | -4016724.637% |
| Endonovo Therapeutics, Inc. | 639.65 Thousand USD | -390796.513% |
| Itoco Inc. | 1.4 Million USD | -178490.315% |
| Rasna Therapeutics, Inc. | 95.65 Thousand USD | -2613815.343% |
| Pathfinder Cell Therapy, Inc. | 106 Thousand USD | -2358761.321% |
| Kadimastem Ltd | 2.3 Million USD | -108420.234% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Institute of Biomedical Research Corp. | 76.35 Thousand USD | -3274637.407% |
| CytoDyn Inc. | 11.13 Million USD | -22353.242% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | 142.97 Thousand USD | -1748769.009% |
| Mobile Lads Corp. | 52.00 USD | -4808447976.923% |
| NanoSphere Health Sciences Inc. | 17.88 Thousand USD | -13984200.895% |
| Qrons Inc. | 420.00 USD | -595331566.667% |
| Alseres Pharmaceuticals, Inc. | 385.47 Thousand USD | -648559.173% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| Nascent Biotech, Inc. | 552.12 Thousand USD | -452771.296% |
| Rebus Holdings, Inc. | 5000.00 USD | -50007760.0% |
| ImmunoCellular Therapeutics, Ltd. | 409.42 Thousand USD | -610612.907% |
| International Stem Cell Corporation | 5.39 Million USD | -46289.481% |
| Bioxytran, Inc. | 137.63 Thousand USD | -1816544.386% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | 15 Million USD | -16567.253% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | - USD | -Infinity% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | 16.57 Million USD | -14981.688% |
| Adhera Therapeutics, Inc. | 79 Thousand USD | -3164954.43% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | 864.67 Thousand USD | -289070.754% |
| Innovation Pharmaceuticals Inc. | 7.51 Million USD | -33163.177% |
| Neutra Corp. | 2851.00 USD | -87702214.977% |
| Windtree Therapeutics, Inc. | 32.4 Million USD | -7615.833% |
| PureTech Health plc | 693.97 Million USD | -260.301% |
| Coeptis Therapeutics, Inc. | 8.07 Million USD | -30879.624% |
| IXICO plc | 15.84 Million USD | -15681.421% |
| IntelGenx Technologies Corp. | 8.28 Million USD | -30090.691% |
| Gelesis Holdings, Inc. | 103.32 Million USD | -2319.954% |
| CSL Limited | 38.02 Billion USD | 93.424% |
| Cellectis S.A. | 333.99 Million USD | -648.633% |